Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Yunnan Baiyao Acquires Two Small Pharmas

publication date: Nov 29, 2007
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Yunnan Baiyao Group Co., Ltd. will buy two smaller pharmaceutical companies for a total of 50 million RMB ($6.8 million). Yunnan will pay 37 million RMB ($5 million) for Kunming Xingzhong Pharmaceutical Co. and 13 million RMB ($1.8 million) for Kunming Yunjian Pharmaceutical Co. The reason for the purchase seems to be the added production capacity the acquisitions would bring, because the ongoing business of each company adds only an extremely small fraction onto the business of Yunnan Baiyao, which has a market cap of $2 billion.  More details...

Stock Symbol: (SZSE: 000538)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...